ABCC1 p.Glu1455Gln
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 12882957
[PubMed]
Payen LF et al: "Role of carboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1)."
No.
Sentence
Comment
78
The forward primers for D793Q, D793N, D793S, E1455Q, E1455N, E1455S, and E1455L were 5Ј-GCTGACATTTACCTCTTCGATCAACCGCTCTC- AGCAGTGGATGCC-3Ј, 5Ј-GCTGACATTTACCTCTTCGATAATCCGC- TCTCAGCAGTGGATGCC-3Ј, 5Ј-GCTGACATTTACCTCTTCGATTCT- CCCCTCTCAGCAGTGGATGCC-3Ј, 5Ј-CGAAGATCCTTGTGTTGGA- TCAGGCCACGGCGGCCGTGGACCTGG-3Ј, 5Ј-CGAAGATCCTTGTG- TTGGATA ACGCCACGGCCGCCGTGGACCTGG-3Ј, 5Ј-CGAAGATCC- TTGTGTTGGATTCGGCCACGGCAGCCGTGGACCTGG-3Ј, 5Ј-CGAA- GATCCTTGTGTTGGATTTGGCCACGGCCGCCGTGGACCTGG-3Ј, respectively.
X
ABCC1 p.Glu1455Gln 12882957:78:45
status: NEW241 To determine whether there may be additional consequences to eliminating the carboxylate side chain, we mutated Asp793 and Glu1455 to Asn, Gln, and Ser as observed in cystic fibrosis transmembrane conductance regulator.
X
ABCC1 p.Glu1455Gln 12882957:241:123
status: NEW245 The exception was the NH2-proximal of the E1455Q mutant that was expressed at a level 1.75 times higher than its COOH-proximal half (Fig. 7A).
X
ABCC1 p.Glu1455Gln 12882957:245:42
status: NEW246 Because the ATP-dependent uptake of LTC4 relies upon association of both halves of the protein and the levels of all COOH-proximal fragments were comparable, no adjustment was made to compensate for the increased expression of the NH2-proximal half of E1455Q (Fig. 7A).
X
ABCC1 p.Glu1455Gln 12882957:246:252
status: NEW249 In contrast, the NBD2 mutations (E1455S, E1455N, E1455Q, and E1455L) like E1455D completely abolished LTC4 transport (Fig. 7B).
X
ABCC1 p.Glu1455Gln 12882957:249:49
status: NEW261 Labeling of the wild-type NBD1 co-expressed with the E1455Q mutation appears to be increased, but we cannot completely exclude the possibility that this is attributable at least in part to the 1.75-fold higher level of expression of this fragment.
X
ABCC1 p.Glu1455Gln 12882957:261:53
status: NEW269 The E1455Q FIG. 7.
X
ABCC1 p.Glu1455Gln 12882957:269:4
status: NEW270 Effect of D793Q, D793N, D793S, E1455S, E1455Q, E1455N, E1455L mutations on [3 H]LTC4 transport activity.
X
ABCC1 p.Glu1455Gln 12882957:270:39
status: NEW271 A, membrane proteins (1 g) from Sf21 cells expressing both halves of either MRP1 (MRP1 dh) or mutant proteins (D793Q, D793N, D793S, E1455S, E1455Q, E1455N, E1455L) were separated by SDS-PAGE on gradient gels and transferred to Immobilon-P membranes.
X
ABCC1 p.Glu1455Gln 12882957:271:148
status: NEW275 B, membrane vesicles (2 g) containing MRP1 dh, D793Q, D793S, D793N, E1455Q, E1455S, E1455N, E1455L, or beta-Gus were assayed for ATP-dependent LTC4 transport activity at 23 °C for up to 3 min in transport buffer containing [3 H]LTC4 (50 nM, 0.13 Ci), as described under "Experimental Procedures."
X
ABCC1 p.Glu1455Gln 12882957:275:76
status: NEW280 These observations are consistent with NBD2 of the E1455Q mutant being occupied predominantly by ADP in the presence of vanadate, whereas in the other mutations that display significant levels of vanadate independent binding, the photolabeling of NBD2 may be the result of occupancy by either ATP or ADP.
X
ABCC1 p.Glu1455Gln 12882957:280:51
status: NEW304 Comparison of nucleotide binding and vanadate trapping by wild-type MRP1 and mutant proteins (D793Q, D793N, D793S, E1455S, E1455Q, E1455N, and E1455L).
X
ABCC1 p.Glu1455Gln 12882957:304:123
status: NEW305 A, at 4 °C, 8-azido- [␣-32 P]ATP photolabeling by wild-type MRP1 and mutant proteins (D793Q, D793N, D793S, E1455S, E1455Q, E1455N, and E1455L) was evaluated. Membrane vesicles (20 g) were incubated with 5 M 8-azido-[␣-32 P]ATP for 5 min on ice in transport buffer containing 5 mM MgCl2.
X
ABCC1 p.Glu1455Gln 12882957:305:127
status: NEW308 The position of the labeled MRP1 NH2-half and COOH-half polypeptides are indicated, and endogenous proteins labeled are indicated by E followed by arrows. B and C, at 37 °C under trapping conditions, 8-azido-[␣-32 P]ADP trapping by wild-type MRP1 mutant proteins (D793Q, D793N, D793S, E1455S, E1455Q, E1455N, and E1455L) was studied.
X
ABCC1 p.Glu1455Gln 12882957:308:305
status: NEW342 Like the E1455D mutation, the substitution of Glu1455 with Gln, Asn, Leu, and Ser completely abolished LTC4 transport activity (Fig. 7B).
X
ABCC1 p.Glu1455Gln 12882957:342:46
status: NEW349 Thus the behavior of the MRP1 Glu1455 to Gln mutation is similar to that of the comparable inactivating mutation in human P-GP, whereas the other mutations appear to block ADP release, as reported in studies of murine mdr3 (32, 33).
X
ABCC1 p.Glu1455Gln 12882957:349:30
status: NEW
PMID: 15737336
[PubMed]
Yang R et al: "Nucleotide dissociation from NBD1 promotes solute transport by MRP1."
No.
Sentence
Comment
42
The definition of D793E means that the D793E mutated N-half is co-expressed with wild-type C-half and E1455Q, the wild-type N-half co-expressed with E1455Q mutated C-half.
X
ABCC1 p.Glu1455Gln 15737336:42:102
status: NEWX
ABCC1 p.Glu1455Gln 15737336:42:149
status: NEW44 Membrane vesicles were prepared from Sf21 cells infected with viral particles expressing pDual without MRP1 cDNA insertion (lane 1), wild-type N-half+wild-type C-half (Wild-type, lanes 2-4), D793E mutated N-half+wild-type C-half (D793E, lanes 5-7), D793L mutated N-half+wild-type C-half (D793L, lanes 8-10), D793N mutated N-half+wild-type C-half (D793N, lanes 11-13) and wild-type N-half+E1455Q mutated C-half (E1455Q, lanes 14-16).
X
ABCC1 p.Glu1455Gln 15737336:44:411
status: NEW50 Since the ratio of N-half, for example, D793E mutated N-half, is similar to that of the C-half co-expressed with D793E mutated N-half, the mean ratios of the protein expressions including N-half and C-half are: 0.993F0.168 (D793E), 0.991F0.073 (D793L), 1.151F0.186 (D793N) and 0.921F0.108 (E1455Q).
X
ABCC1 p.Glu1455Gln 15737336:50:290
status: NEW64 This mutation in NBD2 (E1455Q) almost completely eliminates ATP-dependent LTC4 transport.
X
ABCC1 p.Glu1455Gln 15737336:64:23
status: NEW78 Generation of constructs The oligo-nucleotides to introduce the mutations in MRP1 are: MRP/D793E/forward, 5V-CT GAC ATT TAC CTC TTC GAT GAA CCC CTC TCA GCA GTG GAT GCC-3V; MRP/D793E/reverse, 5V-GGC ATC CAC TGC TGA GAG GGG TTC ATC GAA GAG GTA AAT GTC AG-3V; MRP/D793N/forward, 5V-CT GAC ATT TAC CTC TTC GAT AAT CCC CTC TCA GCA GTG GAT GCC -3V; MRP/D793N/reverse, 5V-GGC ATC CAC TGC TGA GAG GGG ATT ATC GAA GAG GTA AAT GTC AG-3V; MRP/ E1455Q/forward, 5V-G AAG ATC CTT GTG TTG GAT CAG GCC ACG GCA GCC GTG GAC CTG G-3V; MRP/ E1455Q/reverse, 5V-C CAG GTC CAC GGC TGC CGT GGC CTG ATC CAA CAC AAG GAT CTT C-3V.
X
ABCC1 p.Glu1455Gln 15737336:78:433
status: NEWX
ABCC1 p.Glu1455Gln 15737336:78:521
status: NEW83 E1455Q was also introduced into the cDNA by the same strategy.
X
ABCC1 p.Glu1455Gln 15737336:83:0
status: NEW92 This strategy was also used to generate constructs expressing D793E, L, and N mutated N-half and E1455Q mutated C-half.
X
ABCC1 p.Glu1455Gln 15737336:92:97
status: NEW94 To make a construct expressing wild-type N-half and E1455Q mutated C-half simultaneously, the ClaI-BspEI fragment derived from pNUT/E1455Q and the RsrII-ClaI fragment from pDual/N-half/C-half were cloned into the RsrII-BspEI fragment derived from pDual/N-half/ C-half, named as pDual/N-half/E1455Q-C-half.
X
ABCC1 p.Glu1455Gln 15737336:94:52
status: NEWX
ABCC1 p.Glu1455Gln 15737336:94:132
status: NEWX
ABCC1 p.Glu1455Gln 15737336:94:291
status: NEW156 Substitution of the Asp residue with a non-acidic amino acid in NBD1 increased the Km and Vmax values for LTC4 in MRP1 mediated transport In order to test whether these Walker B mutations, D793E, D793L and D793N in NBD1 and E1455Q in R. Yang et al.
X
ABCC1 p.Glu1455Gln 15737336:156:224
status: NEW158 Fig. 3 shows that E1455Q is almost completely inactivated, consistent with the previously reported result [43].
X
ABCC1 p.Glu1455Gln 15737336:158:18
status: NEW169 Since the amounts of MRP1 proteins in membrane vesicles containing wild-type, D793E, D793L, D793N and E1455Q are similar (Fig. 1C), the much lower Vmax value of E1455Q than that of the wild-type (Table 1), although the amount of E1455Q (ratio of 0.921) is slightly less than wild-type, indicates a greatly decreased k2 value, which is perhaps directly associated with the greatly diminished ATPase activity at Fig. 3.
X
ABCC1 p.Glu1455Gln 15737336:169:102
status: NEWX
ABCC1 p.Glu1455Gln 15737336:169:161
status: NEWX
ABCC1 p.Glu1455Gln 15737336:169:229
status: NEW174 The samples are: wild-type, wild-type N-half+wild-type C-half; D793E, D793E mutated N-half+wild-type C-half; D793L, D793L mutated N-half+wild-type C-half; D793N, D793N mutated N-half+wild-type C-half and E1455Q, wild-type N-half+E1455Q mutated C-half.
X
ABCC1 p.Glu1455Gln 15737336:174:204
status: NEW175 Table 1 Km and Vmax values (LTC4) of wild-type and mutant MRP1s Sample Km (nM LTC4)a Vmax (pmol LTC4 mgÀ1 minÀ1 )N-half C-half Wild-type Wild-type 59F1 287.5F7.5 D793E Wild-type 110F10 365.0F25.0 D793L Wild-type 100F0 560.0F0.0 D793N Wild-type 105F5 575.0F75.0 Wild-type E1455Q 50F0 37.5F0.5 a The Km values (n=2) and Vmax values (n=2) were derived from Fig. 3.
X
ABCC1 p.Glu1455Gln 15737336:175:281
status: NEW183 / Biochimica et Biophysica Acta 1668 (2005) 248-261 253 the E1455Q mutated NBD2 as shown in Fig. 7M and O; whereas the higher Vmax value (Table 1) of D793L (a ratio of 0.993 indicates that the amount of D793L is slightly less than wild-type) or D793N (ratio of 1.151) indicates a slightly increased k2 value, leading to a higher Km (LTC4) value and a higher rate of ATP-dependent LTC4 transport.
X
ABCC1 p.Glu1455Gln 15737336:183:61
status: NEW185 Combination of D793E, D793L or D793N mutated NBD1 with E1455Q mutated NBD2 does not enhance ATP-dependent LTC4 transport activity The k2 values should be directly associated with the rates of ATP hydrolysis by variant MRP1 mutants.
X
ABCC1 p.Glu1455Gln 15737336:185:55
status: NEW186 The greatly decreased k2 value for E1455Q is interpreted as that mutation of the putative catalytic E1455 residue to a non-acidic amino acid greatly diminishes the rate of ATP hydrolysis at the mutated NBD2.
X
ABCC1 p.Glu1455Gln 15737336:186:35
status: NEW189 In order to test these two possibilities, the D793E, D793L or D793N mutated N-half was co-expressed with the E1455Q mutated C-half.
X
ABCC1 p.Glu1455Gln 15737336:189:109
status: NEW194 D793E, D793L or D793N mutated NBD1 does not enhance the ATP-dependent LTC4 transport activity of E1455Q mutated NBD2.
X
ABCC1 p.Glu1455Gln 15737336:194:97
status: NEW197 The mean ratios of the protein expressions including N-half and C-half are: 1.33F0.11 (E1455Q), 1.49F0.13 (D793E/E1455Q), 0.98F0.05 (D793L/ E1455Q) and 1.88F0.29 (D793N/E1455Q).
X
ABCC1 p.Glu1455Gln 15737336:197:87
status: NEWX
ABCC1 p.Glu1455Gln 15737336:197:113
status: NEWX
ABCC1 p.Glu1455Gln 15737336:197:140
status: NEWX
ABCC1 p.Glu1455Gln 15737336:197:169
status: NEW204 The samples are: wild-type, wild-type N-half+wild-type C-half; D793E, D793E mutated N-half+wild-type C-half; D793L, D793L mutated N-half+wild-type C-half; D793N, D793N mutated N-half+wild-type C-half and E1455Q, wild-type N-half+E1455Q mutated C-half.
X
ABCC1 p.Glu1455Gln 15737336:204:204
status: NEW205 Table 2 Km values (ATP) of wild-type and mutant MRP1s Sample Km (AM ATP)a N-half C-half Wild-type Wild-type 72.2F1.6 D793E Wild-type 106.0F9.7 D793L Wild-type 107.0F7.5 D793N Wild-type 92.0F12.5 Wild-type E1455Q 55.0F0.0 a Km values (for wild-type, D793E, D793L and D793N, n=5; for E1455Q, n=) were derived from corresponding Michaelis-Menten curves shown in Fig. 5. R. Yang et al.
X
ABCC1 p.Glu1455Gln 15737336:205:205
status: NEWX
ABCC1 p.Glu1455Gln 15737336:205:282
status: NEW210 The Km (ATP) value of E1455Q, the putative catalytic base mutant in NBD2, is slightly less than that of wild-type (Table 2), whereas the Km (ATP) values of D793E, D793L and D793N are slightly higher than that of wild-type (Table 2).
X
ABCC1 p.Glu1455Gln 15737336:210:22
status: NEW220 Fig. 6A, D, G, J and M show the autoradiograms reflecting [a-32 P]-8-N3ATP labeling of wild-type, D793E, D793L, D793N and E1455Q. Labeling was quantified by Packard Instant Imager and plotted against the concentration of [a-32 P]-8-N3ATP (Fig. 6B, C, E, F, H, I, K, L, N and O).
X
ABCC1 p.Glu1455Gln 15737336:220:122
status: NEW226 The Kd for E1455Q mutated NBD2 co-expressed with wild-type NBD1 is almost five fold higher than that of wild-type NBD2 (Table 3), implying that the substitution of the putative catalytic E1455 residue with a non-acidic amino acid decreased k1 (lower rate of binding) and/or increased kÀ1 (higher rate of releasing), i.e. lower affinity.
X
ABCC1 p.Glu1455Gln 15737336:226:11
status: NEW237 Fig. 7A, D, G, J and M show the autoradiograms reflecting [g-32 P]-8-N3ATP labeling of wild-type, D793E, D793L, D793N and E1455Q. Labeling was quantified by Packard Instant Imager and plotted against the incubation time (Fig. 7B, C, E, F, H, I, K, L, N and O).
X
ABCC1 p.Glu1455Gln 15737336:237:122
status: NEW240 / Biochimica et Biophysica Acta 1668 (2005) 248-261 255 expected, most of the labeling disappeared within a short time, except for the E1455Q mutated NBD2 (Fig. 7M and O).
X
ABCC1 p.Glu1455Gln 15737336:240:136
status: NEW241 The labeling with [g-32 P]-8-N3ATP at the C-half containing E1455Q mutated NBD2 is increased almost three fold within 2 min incubation at 37 8C and the T1/2 of this mutated NBD2 is much longer than that of wild-type (Table 4).
X
ABCC1 p.Glu1455Gln 15737336:241:60
status: NEW243 / Biochimica et Biophysica Acta 1668 (2005) 248-261256 decreased Kd) at the E1455Q mutated NBD2 at 37 8C, consistent with our previous finding [51]; (2) the bound ATP at the E1455Q mutated NBD2 cannot be efficiently hydrolyzed due to the substitution of the putative catalytic acidic residue with a non-acidic amino acid (greatly decreased k2); (3) the release rate of the bound ATP from this mutated NBD2 is much lower (decreased kÀ1) than that of wild-type, leading to a longer T1/2 value (Table 4).
X
ABCC1 p.Glu1455Gln 15737336:243:77
status: NEWX
ABCC1 p.Glu1455Gln 15737336:243:175
status: NEW245 In addition, the T1/2 value for the wild-type NBD1 co-expressed with E1455Q mutated NBD2 is slightly longer than that of wild-type N-half co-expressed with the wild-type C-half (Table 4), perhaps reflecting the stabilization effect of the bound nucleotide at NBD1 by the occluded nucleotide at NBD2 [28].
X
ABCC1 p.Glu1455Gln 15737336:245:69
status: NEW246 These results are consistent with the lower Km (ATP) value of E1455Q than that of the wild-type (Table 2) and the low ability to transport LTC4 (Figs. 3 and 5).
X
ABCC1 p.Glu1455Gln 15737336:246:62
status: NEW247 In the cases of D793E, D793L and D793N, the T1/2 values (for NBD1 and NBD2) are shorter than that of the wild-type and E1455Q (Table 4).
X
ABCC1 p.Glu1455Gln 15737336:247:119
status: NEW259 The substitution of the counterpart putative catalytic residue E1455 with a non-acidic amino acid (E1455Q) almost completely abolished the ATP-dependent LTC4 transport (Figs. 3 and 5), presumably due to the greatly decreased ATPase activity of this E1455Q mutated NBD2 (Fig. 7M and O).
X
ABCC1 p.Glu1455Gln 15737336:259:99
status: NEWX
ABCC1 p.Glu1455Gln 15737336:259:249
status: NEW263 In addition, the substitution of this putative catalytic residue D793 with a longer spacer-arm negatively charged Glu enhances its hydrolytic capacity [43], but does not increase the ATP-dependent solute transport activity of D793E/E1455Q mutated MRP1 (Fig. 4) or markedly Fig. 6.
X
ABCC1 p.Glu1455Gln 15737336:263:232
status: NEW273 N and O: Wild-type N-half (N) co-expressed with E1455Q mutated C-half (O).
X
ABCC1 p.Glu1455Gln 15737336:273:48
status: NEW274 Table 3 Substitution of D793 with a non-acidic amino acid decreases affinity for ATP Sample Kd of NBD1 (AM ATP)a Kd of NBD2 (AM ATP)N-half C-half Wild-type Wild-type 11.7F2.8 32.7F2.3 D793E Wild-type 7.8F4.1 41.0F8.1 D793L Wild-type 30.5F2.5 32.9F1.9 D793N Wild-type 28.4F4.5 33.7F0.7 Wild-type E1455Q 19.4F3.3 155.8F9.0 a The Kd (AM ATP) values (for wild-type, n=12; D793E, n=9; D793L and E1455Q, n=; D793N, n=8) were derived from Fig. 6. R. Yang et al.
X
ABCC1 p.Glu1455Gln 15737336:274:295
status: NEWX
ABCC1 p.Glu1455Gln 15737336:274:390
status: NEW283 The substitution of the putative catalytic E1455 with a non-acidic amino acid Q greatly increased the Kd (ATP) of the E1455Q mutated NBD2 (Fig. 6 and Table 3), meaning increased kÀ1 and decreased k1 on ice.
X
ABCC1 p.Glu1455Gln 15737336:283:118
status: NEW284 This E1455Q mutation at NBD2 also has a negative effect on the co-expressed wild-type NBD1, leading to the increased Kd (Table 3), indicating the increased kÀ1 and decreased k1 on ice.
X
ABCC1 p.Glu1455Gln 15737336:284:5
status: NEW285 However, the properties of the E1455Q mutated protein at 37 8C are different from that on ice.
X
ABCC1 p.Glu1455Gln 15737336:285:31
status: NEW286 The [g-32 P]-8-N3ATP bound to the E1455Q mutated NBD2 cannot be efficiently hydrolyzed (greatly decreased k2) but occluded there (decreased kÀ1) (Fig. 7M and Table 4); in the meantime, the occluded [g-32 P]-8-N3ATP at the E1455Q mutated NBD2 stabilized the bound [g-32 P]-8-N3ATP [28] at the wild-type NBD1 co-expressed with the E1455Q mutated NBD2 (Fig. 7N), meaning decreased kÀ1; all these changes lead to a decreased Km (ATP) value and an inability to transport LTC4 (Table 1 and 2).
X
ABCC1 p.Glu1455Gln 15737336:286:34
status: NEWX
ABCC1 p.Glu1455Gln 15737336:286:227
status: NEWX
ABCC1 p.Glu1455Gln 15737336:286:334
status: NEW295 E1455Q mutated NBD2 greatly diminishes the rate of ATP hydrolysis at the mutated NBD2.
X
ABCC1 p.Glu1455Gln 15737336:295:0
status: NEW309 N and O: Wild-type N-half (N) co-expressed with E1455Q mutated C-half (O).
X
ABCC1 p.Glu1455Gln 15737336:309:48
status: NEW310 Table 4 Release rate of the bound nucleotide at the wild-type and mutated NBDs Sample T1/2 of NBD1 (min)a T1/2 of NBD2 (min)N-half C-half Wild-type Wild-type 5.3F0.3 3.7F2.0 D793E Wild-type 3.0F0.7 3.4F1.0 D793L Wild-type 2.3 2.3 D793N Wild-type 2.5F0.5 2.2F0.7 Wild-type E1455Q 6.1F0.3 25.6F2.4 a The T1/2 value (for wild-type, D793E, D793N and E1455Q, n=3; for D793L, n=1) is the time required to release 50% of the bound nucleotide and was derived from Fig. 7. R. Yang et al.
X
ABCC1 p.Glu1455Gln 15737336:310:272
status: NEWX
ABCC1 p.Glu1455Gln 15737336:310:346
status: NEW
PMID: 16551273
[PubMed]
Buyse F et al: "Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis."
No.
Sentence
Comment
220
Considering the data accumulated from other NBD2 mutants, such as Y1302C, E1455Q, H1486F and H1486L, the conformational alterations caused by the K1333L mutation may not be the only reason preventing ATP hydrolysis at the mutated site.
X
ABCC1 p.Glu1455Gln 16551273:220:74
status: NEW
PMID: 17295059
[PubMed]
Chang XB et al: "A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1."
No.
Sentence
Comment
261
This conclusion is further supported by mutation of the putative catalytic residue E1455 in NBD2 that all the mutants, including E1455S, E1455Q, E1455N, E1455L and E1455D, lost their abilities to transport LTC4 across membrane bilayer [62, 144].
X
ABCC1 p.Glu1455Gln 17295059:261:137
status: NEW
PMID: 18636743
[PubMed]
Yang R et al: "Interaction between the bound Mg.ATP and the Walker A serine residue in NBD2 of multidrug resistance-associated protein MRP1 plays a crucial role for the ATP-dependent leukotriene C4 transport."
No.
Sentence
Comment
160
In order to test this hypothesis, membrane vesicles containing these mutants were used to label them with 3 H-LTC4 in the presence or absence of 1 mM ATP and vanadate. As shown in Figure 7, the 3 H-LTC4 labeling on wild type MRP1 and S1334T as well as E1455Q is almost completely inhibited by the presence of ATP and vanadate.
X
ABCC1 p.Glu1455Gln 18636743:160:252
status: NEW183 This inhibitory effect is directly related to nucleotide binding, but not hydrolysis, at NBD1 and NBD2 since the E1455Q mutation, which abolished ATP hydrolysis but not binding (12), exerted similar ability as wild type MRP1 to inhibit the LTC4 binding (Figure 7).
X
ABCC1 p.Glu1455Gln 18636743:183:113
status: NEW
PMID: 19285030
[PubMed]
Wan L et al: "Characterization of the ATPase activity of a novel chimeric fusion protein consisting of the two nucleotide binding domains of MRP1."
No.
Sentence
Comment
4
Additionally, the E1455Q mutant was found to be nonfunctional.
X
ABCC1 p.Glu1455Gln 19285030:4:18
status: NEW33 In order to introduce the E1455Q mutation into NBD2 of the pET21a-NBD1-GST-NBD2 construct, primers 50 -GAA GAT CCT TGT GTT GGA TCA GGC CAC GGC AGC CGT GGA CCT GG-30 and 50 -CCA GGT CCA CGG CTG CCG TGG CCT GAT CCA ACA CAA GGA TCT TC-3` were used, and pET21a-NBD1-GST-NBD2 construct was used as template in the mutagenesis using QuikChange site directed mutagenesis kit (Stratagene).
X
ABCC1 p.Glu1455Gln 19285030:33:26
status: NEW114 To this end, we constructed a NBD1-GST-NBD1 fusion protein and an E1455Q mutant of the NBD1-GST-NBD2 fusion protein.
X
ABCC1 p.Glu1455Gln 19285030:114:66
status: NEW116 Similar to isolated NBD1 and NBD2, neither NBD1-GST-NBD1 nor NBD1-GST-NBD2/E1455Q showed any detectable ATPase activity (Fig. 4B).
X
ABCC1 p.Glu1455Gln 19285030:116:75
status: NEW138 (B) ATPase activities of the chimeric fusion protein NBD1-GST-NBD2, the NBD1(+)NBD2 mixture, the NBD1(+)GST-NBD2 mixture, NBD1-GST-NBD1, and NBD1-GST-NBD2/E1455Q, all purified from Superdex 200 columns.
X
ABCC1 p.Glu1455Gln 19285030:138:155
status: NEW163 Among the NBD1-GST-NBD2 mutants, K684L in Walker A of NBD1, K1333L in Walker A of NBD2, and D1454L/E1455L in Walker B of NBD2 were expressed mainly as inclusion bodies in E. coli, and only the E1455Q mutant was expressed in a sufficient quantity of soluble protein to allow activity analysis.
X
ABCC1 p.Glu1455Gln 19285030:163:193
status: NEW164 The results clearly showed that the NBD1-GST-NBD2/ E1455Q mutant was not functional, consistent with a previous report on this null-mutant in the intact MRP1 [22].
X
ABCC1 p.Glu1455Gln 19285030:164:51
status: NEW
PMID: 19949927
[PubMed]
Chang XB et al: "Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1."
No.
Sentence
Comment
151
However, binding of poorly hydrolysable ATP analog ATPgS to wt MRP1 significantly inhibits the 3 H-LTC4 labeling (99, 100), implying that ATPgS binding might be sufficient to transport the bound LTC4 from high to low affinity site. This conclusion was further supported by the fact that ATPgS or ATP binding to the incompetent E1455D or E1455Q mutants, which were unable to hydrolyze the bound ATP, significantly inhibited the 3 H-LTC4 labeling (100, 156, 157).
X
ABCC1 p.Glu1455Gln 19949927:151:339
status: NEW